Helen Eliopoulos

Statistics

Publications

Citations

596

H-Index

Active since

2008

Affiliations

Sarepta Therapeutics (United States)(Current)

Nationwide Children's Hospital

Helen Eliopoulos is an author at Sarepta Therapeutics (United States) specializing in medicine, neuromuscular disorder pharmacotherapy, and muscular dystrophy.

Publications per year

2008–2021

Publications

Phase 0 Clinical Trial of the Poly (ADP-Ribose) Polymerase Inhibitor ABT-888 in Patients With Advanced Malignancies

Shivaani Kummar, Robert J. Kinders, Martin Gutierrez et al. · Journal of Clinical Oncology · 2009 · 329 citations · Full text

Medicine, Oncology, Pharmacology +16

Eteplirsen Treatment Attenuates Respiratory Decline in Ambulatory and Non-Ambulatory Patients with Duchenne Muscular Dystrophy

Navid Khan, Helen Eliopoulos, Lixin Han et al. · Journal of Neuromuscular Diseases · 2019 · 97 citations · Full text

Pharmacy, Pharmacotherapy, Neuromuscular Disorders +13

Long-term treatment with eteplirsen in nonambulatory patients with Duchenne muscular dystrophy

Lindsay N. Alfano, Jay S. Charleston, Anne M. Connolly et al. · Medicine · 2019 · 85 citations · Full text

Medicine, Pharmacotherapy, Musculoskeletal Rehabilitation +15

Comparison of Long-term Ambulatory Function in Patients with Duchenne Muscular Dystrophy Treated with Eteplirsen and Matched Natural History Controls

Jerry R. Mendell, Navid Khan, Nanshi Sha et al. · Journal of Neuromuscular Diseases · 2021 · 52 citations · Full text

Medicine, Neurology, Mobility Rehabilitation +15

Phase 0 Trials: An Industry Perspective

Helen Eliopoulos, Vincent L. Giranda, Robert A. Carr et al. · Clinical Cancer Research · 2008 · 33 citations

Medicine, Oncology, Pharmacology +17

1–5 of 5